All Posts: News Release
-
Technique Developed in Mice Could Aid Detection of Cancer in Dense Breasts
WASHINGTON (September 14, 2022) — A two-pronged approach to imaging breast density in mice, developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, resulted in better detection of changes in breast tissue, including spotting early signs of cancer. The researchers hope that this approach will be translated from mice and improve breast imaging for people; […]
Category: News Release
-
Informing Children of a Mother’s Genetic Cancer Risk Does Not Impact Their Health Behaviors
WASHINGTON (July 21, 2022) — Telling a child about their mother’s risk of hereditary breast and ovarian cancer does not adversely influence the offspring’s lifestyle or quality of life in the long term, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding appeared July 21, 2022, in Pediatrics […]
Category: News Release
-
Georgetown Lombardi Comprehensive Cancer Center Launches BellRinger, Local Bike Ride to End Cancer
Bike ride to raise millions to fund cancer research with inaugural October ride WASHINGTON (July 18, 2022) — Today, Georgetown Lombardi Comprehensive Cancer Center launched BellRinger, a bike ride and community movement to end cancer. BellRinger opened registration for its inaugural 25-, 50-, and 100- mile fundraising ride on Saturday, October 22, 2022 that will […]
Category: News Release
-
Intensive Telephone-Based Cessation Counseling Results in Improved Smoking Quit Rates
WASHINGTON (July 12, 2022) — Offering intensive, weekly telephone-based cessation counseling along with nicotine replacement for people who smoke and who were undergoing screening for lung cancer resulted in over a twofold greater cigarette quit rate compared to people who received minimal counseling and nicotine replacement, according to results of a national, randomized trial conducted […]
Category: News Release
-
Biomarkers Found That Could Be Drug Targets Against a Deadly Form of Brain Cancer
WASHINGTON (June 22, 2022) — Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing hope for a cancer that is highly lethal. Currently, the drug most often used to treat glioblastoma, temozolomide, is uniquely able to cross the blood/brain […]
Category: News Release
-
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities
Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]
Category: News Release
-
Study Shows Sleep Disturbances During the Pandemic Were Similar between Breast Cancer Survivors and Healthy Controls
WASHINGTON (May 2, 2022) — Results from the Thinking and Living with Cancer Study (TLC) showed that the development of sleep disturbances during the early months of the COVID-19 pandemic increased symptoms of depression and anxiety among older women, but the findings did not differ between women who survived breast cancer and women without cancer. […]
Category: News Release
-
Biological Pathways Found That Drive Genomic Changes and Bone Metastasis in Ewing Sarcoma, a Rare Childhood Cancer
WASHINGTON (April 28, 2022) — In studies using mice grafted with human Ewing sarcoma tissue, researchers from Georgetown University Medical Center and colleagues have identified a biological pathway that is activated when tissue is starved of oxygen due to rapid growth of a tumor, thereby allowing cancer cells to make genetic changes so they can […]
Category: News Release
-
New Factors That Can Predict Breast Cancer Recurrence Defined
Discovery Has the Potential to Also Benefit Treatment Choices. WASHINGTON (April 22, 2022) — Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing new research avenues for preventing a new tumor from developing. […]
Category: News Release
-
MRI May Lower Breast Cancer Deaths From Variants in Three Genes
Variants in these genes are as prevalent as the BRCA1/2 mutations. An analysis suggests annual MRI starting at age 30-35 would cut cancer mortality by 50%. WASHINGTON (February 17, 2022) — Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes […]
Category: News Release